Videos

December 05, 2022

Michael L. Krychman, MD, and Jack D. Sobel, MD, review the mechanisms of ibrexafungerp and how it might fit in the treatment spectrum for RVVC.

December 05, 2022

Michael L. Krychman, MD, and Jack D. Sobel, MD, review the clinical implications of the recent approval of oteseconazole, which has been shown to be efficacious and well tolerated in RVVC treatment.

November 29, 2022

Sarah Crafton, MD, details how sentinel lymph node mapping can help identify the stage of uterine cancers and lead to better patient care.

November 28, 2022

Jeanette Carpenter, MD, MSCI, maternal-fetal medicine specialist at Pediatrix Medical Group, discussed a recently published study regarding pregnant COVID-19 patients who also had disseminated intravascular coagulation (DIC).

November 28, 2022

Thought leaders discuss the history of RVVC treatment, including the use of unapproved topical antifungals and the shortcomings of fluconazole.

November 28, 2022

Michael L. Krychman, MD, and Jack D. Sobel, MD, explore avenues for confirming a diagnosis of RVVC, including cultures and molecular testing.

November 21, 2022

Michael L. Krychman, MD, and Jack D. Sobel, MD, review diagnostic criteria of diagnosis of RVVC and the impact of misdiagnosis.

November 21, 2022

Michael L. Krychman, MD and Jack D. Sobel, MD, talk about the signs and symptoms of vulvovaginal candidiasis as well as its effect on patient quality of life.

November 17, 2022

Charlene Gamaldo, MD, discusses patient criteria for selecting a dual orexin receptor agonist (DORA) for insomnia treatment.

November 17, 2022

An overview of dual orexin receptor agonists (DORAs) therapy for the treatment of insomnia in female patients.